References
- Yilmaz S. et al. A study of coronary artery disease in young patients. Folia Cardiologica 2017; 12, 6: 543–550. DOI: 10.5603/FC.2017.0104
- Anghel L. et al. Particularities of Acute Myocardial Infarction in Young Adults. Journal of Cardiovascular Emergencies 2019; 5(1): 25-31. DOI: 10.2478/jce-2019-0005
- Gulati R. et al. Acute Myocardial Infarction in Young Individuals. Mayo Clin Proc. 2020; 95(1): 136-156. https://doi.org/10.1016/j.mayocp.2019.05.001
- Shah N, Kelly AM, Cox N, Wong C, Soon K. Myocardial Infarction in the “Young”: Risk Factors, Presentation, Management and Prognosis. Heart Lung Circ. 2016 Oct; 25(10): 955-60. DOI: 10.1016/j.hlc.2016.04.015. Epub 2016 May 16. PMID: 27265644.
- Aggarwal A, Srivastava S, Velmurugan M. Newer perspectives of coronary artery disease in young. World J Cardiol 2016 December 26; 8(12): 728-734. DOI: 10.4330/wjc.v8.i12.728
- Lei L, Bin Z. Risk Factor Differences in Acute Myocardial Infarction between Young and Older People: A Systematic Review and Meta-Analysis. Int J Cardiovasc Sci. 2019; 32 (2): 163-176
- Yamac, Aylin Hatice, et al. Premature Myocardial Infarction: Genetic Variations in SIRT1 Affect Disease Susceptibility. Cardiology Research and Practice, 2019. https://doi.org/10.1155/2019/8921806
- Maroszynska-Dmoch EM, Wozakowska-Kaplon B. Clinical and angiographic characteristics of coronary artery disease in young adults: a single centre study. Kardiologia Polska 2016; 74, 4: 314–321. DOI: 10.5603/KP.a2015.0178.
- Connelly JJ et al. GATA2 Is Associated with Familial Early-Onset Coronary Artery Disease. PLoS Genet 2006; 2 (8): e139. DOI 10.1371/journal.pgen.0020139.
- McPherson R., Tybjaerg-Hansen A. Genetics of Coronary Artery Diasease. Circ Res. 2016; 118: 564-578. DOI: 10.1161/CIRCRESAHA.115.306566.
- Musunuru K, Kathiresan S. Genetics of Common, Complex Coronary Artery Disease. Cell. 2019 Mar 21; 177 (1): 132-145. DOI: 10.1016/j. cell.2019.02.015. PMID: 30901535.
- Dalepiane VLN, Silvello DN, Paludo CA, Roisenberg I, Simon D. Matrix metalloproteinase gene polymorphisms in patients with coronary artery disease. Genetics and Molecular Biology, 2007. 30 (3), 505-510. https://doi.org/10.1590/S1415-47572007000400001
- Khera AV, Kathiresan S. Genetics of coronary artery disease: discovery, biology and clinical translation. Nat Rev Genet. 2017 June; 18 (6): 331-344. DOI: 10.1038/nrg.2016.160.
- Hassanzadeh-Makoui R, Razi B, Aslani S, Imani D, Tabaee S. The association between Matrix Metallo-proteinases-9 (MMP-9) gene family polymorphisms and risk of Coronary Artery Disease (CAD): a systematic review and meta-analysis. BMC Cardiovascular Disorders 2020. 20:232. DOI: 10.1186/s12872-020-01510-4.
- Roberts R. et al. Idenifying genes for coronary artery disease: An idea whose time has come. Can J Cardiol 2007; 23 (Suppl A): 7A-15A.
- Al-Koofee DAF, Mubarak SMH. Genetic Polymorphisms. The Recent Topics in Genetic Polymorphisms 2019. IntechOpen, DOI: 10.5772/intechopen.88063
- Assimes TL, Roberts R. Genetics: Implications for Prevention and Management of Coronary Artery Disease. JACC 2016; vol. 68, No 25: 2797-818. DOI: 10.1016/j.jacc.2016.10.039
- Kapoor C. et al. Seesaw of matrix metalloproteinases (MMPs). J Can Res Ther 2016; 12: 28-35. DOI: 10.4103/0973-1482.157337
- Ikeda U, Shimada K. Matrix Metalloproteinase and Coronary Artery Diseases. Clin Cardiol 2003; 26: 55-59
- Kondapalli MS et al. Matrix Metalloproteinases in Coronary Artery Disease: A Review. J Life Sci 2012; 4 (1): 55-58
- Zhang MM et al. Association between matrix metalloproteinase 9 C-1562T polymorphism and the risk of coronary artery disease: an update systematic review and meta-analysis. Oncotarget, 2018; 9 (10): 9468-9479
- Wang L. et al. Association of MMP-9 gene polymorphisms with acute coronary syndrome in the Uygur population iof China. World J Emerg Med 2011; 2 (2): 104-110. DOI: 10.5847/wjem.j.1920-8642.2011.02.005
- Beton O. et al. Association between MMP-3 and MMP-9 polymorphisms and coronary artery disease. Biomedical reports 2016; 5: 709-714. DOI: 10.3892/br.2016.782
- Juan Z, Wei-Guo Z, Heng-Lang S, Da-Guo W. Association of Matrix Metalloprotienase 9 C-1562 Polymorhpism With Genetic Susceptibility to Myocardial Infarction: A Meta-Analysis. Current Therapeutic Research 2015; 77: 40-45. DOI: 10.1016/j.curtheres.2014.05.001
- Rodriguez-Perez J. et al. rs3918242 MMP-9 gene polymorphism is associated with myocar-dial infarction in Mexican patients. Genet Mol Res. 2016;15(1): 15017776
- Mahmoodi K. et al. Plasma concentration, genetic variation, and gene expression levels of matrix metalloproteinase 9 in Iranian patients with coronary artery disease. J Res Med Sci. 2017;22(8):357-62
- Zhang F-X. et al. Association between− 1562C> T polymorphism in the promoter region of matrix metalloproteinase-9 and coronary artery disease: a meta-analysis. Genet Test Mol Bio-markers. 2014;18(2):98–105
- Li Y-Y. et al. Matrix metalloproteinase-9 gene-1562C> T gene polymorphism and coronary artery disease in the Chinese Han population: a meta-analysis of 5468 subjects. Front Physiol. 2016;7:212.
- Watson C. et al. Investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in Irish Caucasian patients with diabetes: a report from the STOP-HF follow-up programme. BMC Cardiovasc Disord (2021) 21:87. https://doi.org/10.1186/s12872-021-01860-7
- Iqbal R. et al. Association of MMP9 Polymorphism With Myocardial Infarction. Interv. Cardiol. (2022) 14,S10: 229-237. DOI: 10.37532/1755-5310.2022.14(S10).229
- Feng B., Li H. Genetic Polymorphism of Matrix Metalloproteinase-9 and Susceptibility to Myocardial Infarction: A Meta-Analysis. Disease Markers, Volume 2022. Article ID 5507153. https://doi.org/10.1155/2022/5507153